RAD51AP1 and esophageal squamous cell carcinoma: RAD51AP1 silencing significantly inhibited cell proliferation and invasion in esophageal squamous cell carcinoma (ESCC), thereby highlighting its potential as a novel target for ESCC treatment [47].